Following promising clinical data , retatrutide, a new peptide treatment for treating adult-onset hyperglycemia , has obtained conditional approval from Great Britain's Drug and Healthcare Agency (MHRA https://sachinzqsg941383.webbuzzfeed.com/41570586/retatrutide-compound-peptide-british-authorization-and-availability